- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
US Cannabis Deals Don’t Need Federal Legalization to Move Forward
Canopy Growth Corporation (TSX:WEED,NYSE:CGC) Founder, Chairman and co-CEO Bruce Linton was featured in an interview with BNN Bloomberg where he discussed the company’s US$3.4-billion deal to acquire Acreage Holdings.
Canopy Growth Corporation (TSX:WEED,NYSE:CGC) Founder, Chairman and co-CEO Bruce Linton was featured in an interview with BNN Bloomberg where he discussed the company’s US$3.4-billion deal to acquire Acreage Holdings, Inc. (CSE:ACGR.U,OTC:ACRGF,FWB:0ZV), a vertically-integrated US cannabis company with operations in 19 states. Under the terms of the acquisition, Canopy Growth retains the right to acquire Acreage once cannabis production and sale becomes federally legal in the US. The two companies will also be executing a license agreement that will allow Acreage to access Canopy Growth’s award-winning brands such as Tweed and Tokyo Smoke, along with other intellectual property.
According to Linton, Canopy Growth has been working on this deal with Acreage since November 2018. He believes that the agreement will provide tremendous value to shareholders once the companies combine their businesses, sharing intellectual property and trade secrets.
Linton also believes that their deal with Acreage is easily replicable for other cannabis and biopharma companies. He pointed out that Canopy Growth was able to go after the company that it wanted because Acreage’s brands and assets complemented Canopy Growth’s existing portfolio. Linton, however, believes that these types of deals will become more costly and involve more players as Canadian companies attempt to enter the US cannabis market.
To listen to the full interview, click here.
Click here to connect with Acreage Holdings for an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.